Can depression be a menopause-associated risk?

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Soares, Claudio N ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN; NORADRENALIN;

ARTICLE; DEPRESSION; FEMALE; FOLLOW UP; HOT FLUSH; HUMAN; LIFE STRESS; MENOPAUSE; POSTMENOPAUSE; PREMENSTRUAL SYNDROME; SLEEP DISORDER; EDITORIAL; PSYCHOLOGICAL ASPECT; RISK FACTOR;

DEPRESSION; FEMALE; HUMANS; MENOPAUSE; RISK FACTORS;

EID: 78649511273     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-79     Document Type: Article

References (33)

1. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?. J Psychiatry Neurosci 2008, 33:331-343. 2440795, 18592034.
2. Santoro N, Neal-Perry G. Normal aging and the menopausal transition: what to expect. The Menopausal Transition: Interface Between Psychiatry and Gynecology 2009, 1-17. Basel, Switzerland: Karger, Soares CN, Warren M.
3. Dennerstein L, Smith AM, Morse C. Psychological well-being, mid-life and the menopause. Maturitas 1994, 20:1-11. 10.1016/0378-5122(94)90095-7, 7877515.
4. McKinlay JB, McKinlay SM, Brambilla D. The relative contribution of endocrine changes and social circumstances to depression in mid-aged women. J Health Social Behav 1987, 25:345-363.
5. Woods NF, Mitchell ES. Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health 1997, 20:119-129. 10.1002/(SICI)1098-240X(199704)20:2<119::AID-NUR4>3.0.CO;2-N, 9100742.
6. Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997, 16:203-208. 10.1037/0278-6133.16.3.203, 9152697.
7. Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001, 3:243-249.
8. Bromberger JT, Meyer PM, Kravitz HM, Sommer B, Cordal A, Powell L, Ganz PA, Sutton-Tyrrell K. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 2001, 91:1435-1442. 10.2105/AJPH.91.9.1435, 1446800, 11527777.
9. Joffe H, Soares CN, Thurston RC, White DP, Cohen LS, Hall JE. Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause 2009, 16:671-679. 10.1097/gme.0b013e3181957377, 19197217.
10. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol 1994, 4:214-220. 10.1016/1047-2797(94)90099-X, 8055122.
11. Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007, 103:267-272. 10.1016/j.jad.2007.01.034, 2048765, 17331589.
12. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004, 61:62-70. 10.1001/archpsyc.61.1.62, 14706945.
13. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas 2002, 42:195-200. 10.1016/S0378-5122(02)00038-5, 12161043.
14. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell S. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2008, 15:223-232. 10.1097/gme.0b013e3181450fc2, 18176355.
15. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006, 63:385-390. 10.1001/archpsyc.63.4.385, 16585467.
16. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006, 63:375-382. 10.1001/archpsyc.63.4.375, 16585466.
17. Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, Karlamangla AS. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 2009, 72:1850-1857. 10.1212/WNL.0b013e3181a71193, 2690984, 19470968.
18. Wildman RP, Colvin AB, Powell LH, Matthews KA, Everson-Rose SA, Hollenberg S, Johnston JM, Sutton-Tyrrell K. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008, 15:414-421. 10.1097/gme.0b013e318154b6f5, 2874195, 18209686.
19. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009, 54:2366-2373. 10.1016/j.jacc.2009.10.009, 20082925.
20. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465-1477. 10.1001/jama.297.13.1465, 17405972.
21. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005, 8:3-12. 10.1080/13697130500042417, 15804727.
22. Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 2006, 13:780-786. 10.1097/01.gme.0000240633.46300.fa, 16894334.
23. Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, Cohen LS. Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 2007, 68:943-950. 10.4088/JCP.v68n0619, 17592922.
24. Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan P, Kane CP, Cohen LS. Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause 2010, 17:700-711.
25. Kornstein SG, Jiang Q, Reddy S, Musgnung JJ, Guico-Pabia CJ. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. J Clin Psychiatry 2010, 71:1088-1096. 10.4088/JCP.10m06018blu, 20797382.
26. Soares CN, Frey BN, Haber E, Steiner M. A pilot, 8-week, placebo lead-in trial of quetiapine extended release for depression in midlife women: impact on mood and menopause-related symptoms. J Clin Psychopharmacol 2010, 30:612-615. 10.1097/JCP.0b013e3181f1d0f2, 20814317.
27. Stahl SM. Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 1998, 59(Suppl 4):15-24.
28. Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M. The rapid effects of estrogen: a mini-review. Behav Pharmacol 2010, 21:465-72. 10.1097/FBP.0b013e32833da5c3, 20661136.
29. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo controlled trial. Arch Gen Psychiatry 2001, 58:529-534. 10.1001/archpsyc.58.6.529, 11386980.
30. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000, 183:414-420. 10.1067/mob.2000.106004, 10942479.
31. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004, 55:406-412. 10.1016/j.biopsych.2003.08.011, 14960294.
32. Studd J. Ten reasons to be happy about hormone replacement therapy: a guide for patients. Menopause Int 2010, 16:44-46. 10.1258/mi.2010.010001, 20424287.
33. Martini J, Wittchen HU, Soares CN, Rieder A, Steiner M. New women-specific diagnostic modules: the Composite International Diagnostic Interview for Women (CIDI-VENUS). Arch Womens Ment Health 2009, 12:281-289. 10.1007/s00737-009-0077-2, 19533302.